# ![@AbCelleraBio Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::4779746292.png) @AbCelleraBio AbCellera

AbCellera has reported its Q2 [----] business results. The company also announced that the first participants have been dosed in a Phase [--] clinical trial of ABCL635 for vasomotor symptoms. This trial marks a significant milestone in the development of the treatment.

### Engagements: [--] [#](/creator/twitter::4779746292/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4779746292/c:line/m:interactions.svg)

- [--] Week [------] +1,010,100%
- [--] Month [------] -74%
- [--] Months [------] +91%
- [--] Year [------] +379%

### Mentions: [--] [#](/creator/twitter::4779746292/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4779746292/c:line/m:posts_active.svg)

- [--] Year [--] -43%

### Followers: [-----] [#](/creator/twitter::4779746292/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4779746292/c:line/m:followers.svg)

- [--] Week [-----] +0.39%
- [--] Month [-----] +4.80%
- [--] Months [-----] +18%
- [--] Year [-----] +37%

### CreatorRank: undefined [#](/creator/twitter::4779746292/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4779746292/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  18.18% [stocks](/list/stocks)  15.15% [vc firms](/list/vc-firms)  6.06% [countries](/list/countries)  6.06% [technology brands](/list/technology-brands)  6.06% [financial services](/list/financial-services)  3.03%

**Social topic influence**
[health](/topic/health) 9.09%, [financial](/topic/financial) 9.09%, [targets](/topic/targets) 6.06%, [canada](/topic/canada) 6.06%, [business](/topic/business) 6.06%, [vivo](/topic/vivo) 6.06%, [dr](/topic/dr) 6.06%, [gilead sciences](/topic/gilead-sciences) 3.03%, [atlas venture](/topic/atlas-venture) 3.03%, [regeneron](/topic/regeneron) 3.03%

**Top accounts mentioned or mentioned by**
[@jackprescottx](/creator/undefined) [@abbvie](/creator/undefined) [@invetx](/creator/undefined) [@locktimusslime](/creator/undefined) [@biotechhealthx](/creator/undefined) [@algo_stoney](/creator/undefined) [@ubc](/creator/undefined) [@domm](/creator/undefined) [@jbb561](/creator/undefined) [@iamrocketmen](/creator/undefined) [@sciencevancity](/creator/undefined)

**Top assets mentioned**
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Goldman Sachs (GS)](/topic/goldman-sachs) [AbbVie Inc (ABBV)](/topic/$abbv)
### Top Social Posts
Top posts by engagements in the last [--] hours

"AbCellera Announces First Patients Dosed in Phase [--] Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause https://investors.abcellera.com/news/news-releases/2026/AbCellera-Announces-First-Patients-Dosed-in-Phase-2-Portion-of-its-Phase-12-Clinical-Trial-of-ABCL635-for-the-Treatment-of-Vasomotor-Symptoms-Due-to-Menopause/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/2010714569669505253)  2026-01-12T14:04Z [----] followers, 47.4K engagements


"AbCellera to Present at Upcoming Investor Conferences in March and April [----] https://investors.abcellera.com/news/news-releases/2026/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-March-and-April-2026/default.aspx https://investors.abcellera.com/news/news-releases/2026/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-March-and-April-2026/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/2021692383776452979)  2026-02-11T21:06Z [----] followers, 10.1K engagements


"AbCellera and Gilead Sciences Announce New Multi-Year Multi-Target Antibody Discovery Collaboration http://ow.ly/ph6o50EemUH http://ow.ly/ph6o50EemUH"  
[X Link](https://x.com/AbCelleraBio/status/1377607805851557894)  2021-04-01T13:04Z [----] followers, [--] engagements


"AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients http://ow.ly/iYO350Karci http://ow.ly/iYO350Karci"  
[X Link](https://x.com/AbCelleraBio/status/1554785601471365120)  2022-08-03T11:05Z [----] followers, [--] engagements


"AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron"  
[X Link](https://x.com/AbCelleraBio/status/1704480968856182968)  2023-09-20T13:01Z [----] followers, [----] engagements


"AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June [--] [----] https://ow.ly/cYBL50RZ0fj https://ow.ly/cYBL50RZ0fj"  
[X Link](https://x.com/AbCelleraBio/status/1795547651896725942)  2024-05-28T20:08Z [----] followers, [----] engagements


"AbCellera to Report Third Quarter [----] Financial Results on November [--] [----] https://investors.abcellera.com/news/news-releases/2024/AbCellera-to-Report-Third-Quarter-2024-Financial-Results-on-November-4-2024/default.aspx https://investors.abcellera.com/news/news-releases/2024/AbCellera-to-Report-Third-Quarter-2024-Financial-Results-on-November-4-2024/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/1839396151595774360)  2024-09-26T20:06Z [----] followers, [----] engagements


"AbCellera to Present at Upcoming Investor Conferences in November https://investors.abcellera.com/news/news-releases/2024/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-November-2024/default.aspx https://investors.abcellera.com/news/news-releases/2024/AbCellera-to-Present-at-Upcoming-Investor-Conferences-in-November-2024/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/1848818037006471458)  2024-10-22T20:05Z [----] followers, [----] engagements


"AbCellera to Present at Upcoming Investor Conferences in December and January https://ow.ly/TkPn50Ucg0r https://ow.ly/TkPn50Ucg0r"  
[X Link](https://x.com/AbCelleraBio/status/1859705157228896663)  2024-11-21T21:07Z [----] followers, [----] engagements


"Visit our poster at AET US to explore how tailored T-cell engager design strategies can be leveraged to widen the therapeutic window and enhance efficacy. #AntibodyEng"  
[X Link](https://x.com/AbCelleraBio/status/1867600578102136985)  2024-12-13T16:00Z [----] followers, [----] engagements


"AbCellera Expands Collaboration with @abbvie to Develop Novel T-Cell Engagers for Oncology https://ow.ly/Toyx50UFhrA https://ow.ly/Toyx50UFhrA"  
[X Link](https://x.com/AbCelleraBio/status/1878806972864327853)  2025-01-13T14:11Z [----] followers, [----] engagements


"Visit our poster at #festivalofbiologics in San Diego to learn how were leveraging our T-cell engager (TCE) platform to design and optimize TCEs for solid tumor targets. Read more about our TCE platform: https://tinyurl.com/mrh67e5w https://tinyurl.com/mrh67e5w"  
[X Link](https://x.com/AbCelleraBio/status/1914363816474710100)  2025-04-21T17:01Z [----] followers, [----] engagements


"AbCelleras Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit https://ow.ly/TLEF50VRmta https://ow.ly/TLEF50VRmta"  
[X Link](https://x.com/AbCelleraBio/status/1922012067101294768)  2025-05-12T19:32Z [----] followers, 11.6K engagements


"AbCellera and Bruker Reach Global Settlement of Patent Litigation https://investors.abcellera.com/news/news-releases/2025/AbCellera-and-Bruker-Reach-Global-Settlement-of-Patent-Litigation/default.aspx https://investors.abcellera.com/news/news-releases/2025/AbCellera-and-Bruker-Reach-Global-Settlement-of-Patent-Litigation/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/2001653977591746937)  2025-12-18T14:01Z [----] followers, 42.3K engagements


"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies http://ow.ly/kFla50K5gWo http://ow.ly/kFla50K5gWo"  
[X Link](https://x.com/AbCelleraBio/status/1552248715334795264)  2022-07-27T11:05Z [----] followers, [--] engagements


"Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology https://ow.ly/J0Gi50Q3ecx https://ow.ly/J0Gi50Q3ecx"  
[X Link](https://x.com/AbCelleraBio/status/1719808650783375475)  2023-11-01T20:08Z [----] followers, [----] engagements


"Congratulations to our partner @invetx on its acquisition by Dechra Pharmaceuticals a global leader in animal health. https://www.invetx.com/invetx-announces-upcoming-acquisition-by-dechra-pharmaceuticals-global-leader-in-animal-health/ https://www.invetx.com/invetx-announces-upcoming-acquisition-by-dechra-pharmaceuticals-global-leader-in-animal-health/"  
[X Link](https://x.com/AbCelleraBio/status/1814312063113838912)  2024-07-19T14:51Z [----] followers, [----] engagements


"AbCellera Doses First Participants in a Phase [--] Clinical Trial of ABCL575 https://ow.ly/pmcV50WMLv1 https://ow.ly/pmcV50WMLv1"  
[X Link](https://x.com/AbCelleraBio/status/1960689822734905628)  2025-08-27T13:04Z [----] followers, 15.4K engagements


"AbCellera Receives Authorization from Health Canada to Initiate the Phase [--] Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause https://ow.ly/wZ1o50VSUVU https://ow.ly/wZ1o50VSUVU"  
[X Link](https://x.com/anyuser/status/1922759325031768467)  2025-05-14T21:02Z [----] followers, 14K engagements


"AbCellera Reports Q2 [----] Business Results & First Participants Dosed in a Phase [--] Clinical Trial of ABCL635 for Vasomotor Symptoms https://ow.ly/XtfB50WBHnz https://ow.ly/XtfB50WBHnz"  
[X Link](https://x.com/anyuser/status/1953553709696205265)  2025-08-07T20:27Z [----] followers, 15.7K engagements


"AbCellera Receives Authorization from Health Canada to Initiate a Phase [--] Clinical Trial of ABCL575 https://ow.ly/7GH550W1JLI https://ow.ly/7GH550W1JLI"  
[X Link](https://x.com/AbCelleraBio/status/1928497784275026270)  2025-05-30T17:04Z [----] followers, [----] engagements


"Visit our poster at Antibody Engineering & Therapeutics Europe [----] to learn how we leverage multiple T-cell engager building blocks to generate molecules with in vivo efficacy. Read more about our TCE platform: #AntibodyEngineering https://ow.ly/JzZt50W5EbV https://ow.ly/JzZt50W5EbV"  
[X Link](https://x.com/AbCelleraBio/status/1931033807194341773)  2025-06-06T17:01Z [----] followers, [----] engagements


"Visit our poster at #DiscoveryOnTarget in Boston to learn how our multiple T-cell engager (TCE) building blocks can be leveraged to tailor TCE design for diverse tumor targets. Read more about our TCE platform: https://tinyurl.com/yyv3nk54 https://tinyurl.com/yyv3nk54"  
[X Link](https://x.com/AbCelleraBio/status/1969086622109950242)  2025-09-19T17:10Z [----] followers, 10.7K engagements


"AbCellera to Participate at Upcoming Investor Conferences in November and December [----] https://www.abcellera.com/news/abcellera-to-participate-at-upcoming-investor-conferences-in-november-and-december-2025 https://www.abcellera.com/news/abcellera-to-participate-at-upcoming-investor-conferences-in-november-and-december-2025"  
[X Link](https://x.com/AbCelleraBio/status/1975654959233302700)  2025-10-07T20:10Z [----] followers, 18.1K engagements


"Visit our poster at ACoP [----] Conference to learn how using Quantitative Systems Pharmacology (QSP) models can help predict and explain the diverse in vivo efficacy outcomes of T-cell engagers. Read more about our TCE #pharmacometrics #ISoP #ACoP https://tinyurl.com/a3csf7p3 https://tinyurl.com/a3csf7p3"  
[X Link](https://x.com/anyuser/status/1979236017984147827)  2025-10-17T17:20Z [----] followers, 20.4K engagements


"AbCellera Reports Q3 [----] Business Results https://investors.abcellera.com/news/news-releases/2025/AbCellera-Reports-Q3-2025-Business-Results/default.aspx https://investors.abcellera.com/news/news-releases/2025/AbCellera-Reports-Q3-2025-Business-Results/default.aspx"  
[X Link](https://x.com/anyuser/status/1986540807705502170)  2025-11-06T21:06Z [----] followers, 17.2K engagements


"AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January [--] [----] https://investors.abcellera.com/news/news-releases/2025/AbCellera-to-Present-at-the-44th-Annual-J-P--Morgan-Healthcare-Conference-on-January-14-2026/default.aspx https://investors.abcellera.com/news/news-releases/2025/AbCellera-to-Present-at-the-44th-Annual-J-P--Morgan-Healthcare-Conference-on-January-14-2026/default.aspx"  
[X Link](https://x.com/anyuser/status/1998137129252307403)  2025-12-08T21:06Z [----] followers, [----] engagements


"AbCellera to Report Second Quarter [----] Financial Results on August [--] [----] https://ow.ly/qXk350Wm1Bc https://ow.ly/qXk350Wm1Bc"  
[X Link](https://x.com/AbCelleraBio/status/1942348598043189723)  2025-07-07T22:22Z [----] followers, [----] engagements


"AbCellera to Participate at Upcoming Investor Conferences in September https://ow.ly/LrqQ50WERCr https://ow.ly/LrqQ50WERCr"  
[X Link](https://x.com/AbCelleraBio/status/1955360796768174223)  2025-08-12T20:08Z [----] followers, 12K engagements


"AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer http://www.abcellera.com/news/abcellera-appoints-dr-sarah-noonberg-as-chief-medical-officer http://www.abcellera.com/news/abcellera-appoints-dr-sarah-noonberg-as-chief-medical-officer"  
[X Link](https://x.com/AbCelleraBio/status/1965763501298696420)  2025-09-10T13:05Z [----] followers, [----] engagements


"AbCellera to Report Third Quarter [----] Financial Results on November [--] [----] https://www.abcellera.com/news/abcellera-to-report-third-quarter-2025-financial-results-on-november-6-2025 https://www.abcellera.com/news/abcellera-to-report-third-quarter-2025-financial-results-on-november-6-2025"  
[X Link](https://x.com/AbCelleraBio/status/1972755879742071039)  2025-09-29T20:10Z [----] followers, 10.4K engagements


"AbCellera Appoints Dr. Stephen Quake to its Board of Directors https://investors.abcellera.com/news/news-releases/2025/AbCellera-Appoints-Dr--Stephen-Quake-to-its-Board-of-Directors/default.aspx https://investors.abcellera.com/news/news-releases/2025/AbCellera-Appoints-Dr--Stephen-Quake-to-its-Board-of-Directors/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/1987883651414298759)  2025-11-10T14:02Z [----] followers, 39.7K engagements


"AbCellera to Report Full Year [----] Financial Results on February [--] [----] https://investors.abcellera.com/news/news-releases/2026/AbCellera-to-Report-Full-Year-2025-Financial-Results-on-February-24-2026/default.aspx https://investors.abcellera.com/news/news-releases/2026/AbCellera-to-Report-Full-Year-2025-Financial-Results-on-February-24-2026/default.aspx"  
[X Link](https://x.com/AbCelleraBio/status/2014445806754136566)  2026-01-22T21:11Z [----] followers, 17.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing